USA RNA-Based Therapeutics and Vaccines Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA RNA-Based Therapeutics and Vaccines market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA RNA-Based Therapeutics and Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by RNA-Based Therapeutics and Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • BioNTech

    • Regulus Therapeutics

    • Dicerna Pharmaceuticals

    • MiRagen Therapeutics

    • Alnylam Pharmaceuticals

    • Arrowhead Pharmaceuticals

    • Roche

    • Arbutus Biopharma

    • Moderna Therapeutics

    • CureVac

    • Sylentis

    • Marina Biotech

    • Quark Pharmaceuticals

    By Type:

    • RNA-Based Therapeutics

    • RNA-Based Vaccines

    By End-User:

    • Oncology

    • Immunology

    • Ophthalmology

    • Cardiovascular Diseases

    • Infectious Diseases

    • Genetic Diseases

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of RNA-Based Therapeutics and Vaccines Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Therapeutics from 2016 to 2027

      • 1.3.2 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Vaccines from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Oncology from 2016 to 2027

      • 1.4.2 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Immunology from 2016 to 2027

      • 1.4.3 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Ophthalmology from 2016 to 2027

      • 1.4.4 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

      • 1.4.5 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

      • 1.4.6 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Genetic Diseases from 2016 to 2027

      • 1.4.7 USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of RNA-Based Therapeutics and Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of RNA-Based Therapeutics and Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of RNA-Based Therapeutics

      • 3.4.2 Market Size and Growth Rate of RNA-Based Vaccines

    4 Segmentation of RNA-Based Therapeutics and Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of RNA-Based Therapeutics and Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Oncology

      • 4.4.2 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Immunology

      • 4.4.3 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Ophthalmology

      • 4.4.4 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Cardiovascular Diseases

      • 4.4.5 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Infectious Diseases

      • 4.4.6 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Genetic Diseases

      • 4.4.7 Market Size and Growth Rate of RNA-Based Therapeutics and Vaccines in Others

    5 Market Analysis by Regions

    • 5.1 USA RNA-Based Therapeutics and Vaccines Production Analysis by Regions

    • 5.2 USA RNA-Based Therapeutics and Vaccines Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA RNA-Based Therapeutics and Vaccines Landscape Analysis

    • 6.1 West USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major Types

    • 6.2 West USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major End-Users

    7 South USA RNA-Based Therapeutics and Vaccines Landscape Analysis

    • 7.1 South USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major Types

    • 7.2 South USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major End-Users

    8 Middle West USA RNA-Based Therapeutics and Vaccines Landscape Analysis

    • 8.1 Middle West USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major Types

    • 8.2 Middle West USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major End-Users

    9 Northeast USA RNA-Based Therapeutics and Vaccines Landscape Analysis

    • 9.1 Northeast USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major Types

    • 9.2 Northeast USA RNA-Based Therapeutics and Vaccines Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 BioNTech

        • 10.1.1 BioNTech Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Regulus Therapeutics

        • 10.2.1 Regulus Therapeutics Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Dicerna Pharmaceuticals

        • 10.3.1 Dicerna Pharmaceuticals Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 MiRagen Therapeutics

        • 10.4.1 MiRagen Therapeutics Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Alnylam Pharmaceuticals

        • 10.5.1 Alnylam Pharmaceuticals Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Arrowhead Pharmaceuticals

        • 10.6.1 Arrowhead Pharmaceuticals Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Roche

        • 10.7.1 Roche Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Arbutus Biopharma

        • 10.8.1 Arbutus Biopharma Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Moderna Therapeutics

        • 10.9.1 Moderna Therapeutics Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 CureVac

        • 10.10.1 CureVac Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Sylentis

        • 10.11.1 Sylentis Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Marina Biotech

        • 10.12.1 Marina Biotech Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Quark Pharmaceuticals

        • 10.13.1 Quark Pharmaceuticals Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Therapeutics from 2016 to 2027

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Vaccines from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Immunology from 2016 to 2027

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Ophthalmology from 2016 to 2027

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Genetic Diseases from 2016 to 2027

    • Figure USA RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of RNA-Based Therapeutics and Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of RNA-Based Therapeutics and Vaccines

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of RNA-Based Therapeutics and Vaccines by Different Types from 2016 to 2027

    • Table Consumption Share of RNA-Based Therapeutics and Vaccines by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of RNA-Based Therapeutics

    • Figure Market Size and Growth Rate of RNA-Based Vaccines

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of RNA-Based Therapeutics and Vaccines by Different End-Users from 2016 to 2027

    • Table Consumption Share of RNA-Based Therapeutics and Vaccines by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Immunology

    • Figure Market Size and Growth Rate of Ophthalmology

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Genetic Diseases

    • Figure Market Size and Growth Rate of Others

    • Table USA RNA-Based Therapeutics and Vaccines Production by Regions

    • Table USA RNA-Based Therapeutics and Vaccines Production Share by Regions

    • Figure USA RNA-Based Therapeutics and Vaccines Production Share by Regions in 2016

    • Figure USA RNA-Based Therapeutics and Vaccines Production Share by Regions in 2021

    • Figure USA RNA-Based Therapeutics and Vaccines Production Share by Regions in 2027

    • Table USA RNA-Based Therapeutics and Vaccines Consumption by Regions

    • Table USA RNA-Based Therapeutics and Vaccines Consumption Share by Regions

    • Figure USA RNA-Based Therapeutics and Vaccines Consumption Share by Regions in 2016

    • Figure USA RNA-Based Therapeutics and Vaccines Consumption Share by Regions in 2021

    • Figure USA RNA-Based Therapeutics and Vaccines Consumption Share by Regions in 2027

    • Table West USA RNA-Based Therapeutics and Vaccines Consumption by Types from 2016 to 2027

    • Table West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types from 2016 to 2027

    • Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2016

    • Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2021

    • Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2027

    • Table West USA RNA-Based Therapeutics and Vaccines Consumption by End-Users from 2016 to 2027

    • Table West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2016

    • Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2021

    • Figure West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2027

    • Table South USA RNA-Based Therapeutics and Vaccines Consumption by Types from 2016 to 2027

    • Table South USA RNA-Based Therapeutics and Vaccines Consumption Share by Types from 2016 to 2027

    • Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2016

    • Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2021

    • Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2027

    • Table South USA RNA-Based Therapeutics and Vaccines Consumption by End-Users from 2016 to 2027

    • Table South USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2016

    • Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2021

    • Figure South USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2027

    • Table Middle West USA RNA-Based Therapeutics and Vaccines Consumption by Types from 2016 to 2027

    • Table Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2016

    • Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2021

    • Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2027

    • Table Middle West USA RNA-Based Therapeutics and Vaccines Consumption by End-Users from 2016 to 2027

    • Table Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2016

    • Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2021

    • Figure Middle West USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2027

    • Table Northeast USA RNA-Based Therapeutics and Vaccines Consumption by Types from 2016 to 2027

    • Table Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2016

    • Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2021

    • Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by Types in 2027

    • Table Northeast USA RNA-Based Therapeutics and Vaccines Consumption by End-Users from 2016 to 2027

    • Table Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2016

    • Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2021

    • Figure Northeast USA RNA-Based Therapeutics and Vaccines Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of BioNTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech

    • Figure Sales and Growth Rate Analysis of BioNTech

    • Figure Revenue and Market Share Analysis of BioNTech

    • Table Product and Service Introduction of BioNTech

    • Table Company Profile and Development Status of Regulus Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regulus Therapeutics

    • Figure Sales and Growth Rate Analysis of Regulus Therapeutics

    • Figure Revenue and Market Share Analysis of Regulus Therapeutics

    • Table Product and Service Introduction of Regulus Therapeutics

    • Table Company Profile and Development Status of Dicerna Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals

    • Table Product and Service Introduction of Dicerna Pharmaceuticals

    • Table Company Profile and Development Status of MiRagen Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MiRagen Therapeutics

    • Figure Sales and Growth Rate Analysis of MiRagen Therapeutics

    • Figure Revenue and Market Share Analysis of MiRagen Therapeutics

    • Table Product and Service Introduction of MiRagen Therapeutics

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of Arrowhead Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Arrowhead Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Arrowhead Pharmaceuticals

    • Table Product and Service Introduction of Arrowhead Pharmaceuticals

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Arbutus Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbutus Biopharma

    • Figure Sales and Growth Rate Analysis of Arbutus Biopharma

    • Figure Revenue and Market Share Analysis of Arbutus Biopharma

    • Table Product and Service Introduction of Arbutus Biopharma

    • Table Company Profile and Development Status of Moderna Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics

    • Figure Sales and Growth Rate Analysis of Moderna Therapeutics

    • Figure Revenue and Market Share Analysis of Moderna Therapeutics

    • Table Product and Service Introduction of Moderna Therapeutics

    • Table Company Profile and Development Status of CureVac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac

    • Figure Sales and Growth Rate Analysis of CureVac

    • Figure Revenue and Market Share Analysis of CureVac

    • Table Product and Service Introduction of CureVac

    • Table Company Profile and Development Status of Sylentis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sylentis

    • Figure Sales and Growth Rate Analysis of Sylentis

    • Figure Revenue and Market Share Analysis of Sylentis

    • Table Product and Service Introduction of Sylentis

    • Table Company Profile and Development Status of Marina Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marina Biotech

    • Figure Sales and Growth Rate Analysis of Marina Biotech

    • Figure Revenue and Market Share Analysis of Marina Biotech

    • Table Product and Service Introduction of Marina Biotech

    • Table Company Profile and Development Status of Quark Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Quark Pharmaceuticals

    • Table Product and Service Introduction of Quark Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.